Interested in using your skills for a good cause, a great challenge and a $25,000 prize? How about predicting the future of ALS patients?
Prize4Life is proud to announce the launch of a computational challenge to predict the future progression of disease in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. The DREAM-Phil Bowen ALS Prediction Prize4Life (or ALS Prediction Prize) is being run by Prize4Life in collaboration with The DREAM Project (and the sponsorship of Nature, Popular Science and The Economist) and carries a $25,000 prize for the winning prediction.
The DREAM Phil Bowen ALS Prediction Prize4Life challenge aims to answer a puzzling and problematic question in ALS. It is well known that most ALS patients are like Lou Gehrig: their disease progresses aggressively, quickly leading to death within 2-3 years. However, a small number of patients turn out to be more like Stephen Hawking, where their disease progression is slow and patients can live for 10 or more years. What separates the Lou Gehrigs from the Stephen Hawkings? Solving this mystery is important, both for patients and their families and for those planning clinical trials of new treatments. Now we finally have the data that may hold the key. The only thing missing is you.
The ALS Prediction Prize challenge will be run on the InnoCentive prize platform (https://www.innocentive.com/ar/challenge/9933047).
Use your computational expertise to win a Prize4Life,